US Drug Recall Register
Class II · Moderate risk Ongoing Initiated May 29, 2013 (13 years ago)

Adenosine-Mono-Phosphate Injection

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

What was recalled

Adenosine-Mono-Phosphate Injection, 200 mg/ml, compounded by Olympia Pharmacy, Orlando, FL

Recalling firm
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
Origin
FL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-694-2013

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Adenosine recalls

See all
Class II · Moderate risk Terminated

Adenosine Injection

Reason Lack of Assurance of Sterility

Teva Pharmaceuticals USA NDC 16714-180-01 D-0748-2021
Class II · Moderate risk Terminated

Adenosine Injection

Reason Lack of Assurance of Sterility

Teva Pharmaceuticals USA NDC 0703-8776-01 D-0740-2021
Class II · Moderate risk Terminated

Adenosine all strengths

Reason Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.

Advanced Pharma Inc. D-0832-2017